Brief: Bellus Health To Present Late-Breaking Clinical Data From The Phase 2B Soothe Trial Of Blu-5937
02/05/2022 12:22
May 2 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH TO PRESENT LATE-BREAKING CLINICAL DATA FROM
THE
PHASE 2B SOOTHE TRIAL OF BLU-5937 AT THE ATS 2022 INTERNATIONAL
CONFERENCE
Source text for Eikon: ID:nBw2nwBXFa
Further company coverage: BLU.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln